Potential Benefits of LL-37 Peptide Therapy LL-37 peptide therapy is increasingly explored for its potential role in: Immune regulation Skin barrier support Antimicrobial defense Tissue healing Potential benefits may include: Reduced inflammatory burden Improved skin recovery Enhanced barrier integrity Support for microbial balance Because rosacea involves complex immune pathways, physician supervision is important when considering immune-modulating peptides
In the foundational 2017 Cell study, naturally aged mice and chemotherapy-treated mice received FOXO4-DRI at 5 mg/kg by intraperitoneal (IP) injection , given on an intermittent schedule (about three times per week) across several weeks
Marissa Liza: Thank you
In human keratinocyte studies, AES16-2M significantly reduced TSLP expression
It is being studied in diabetic neuropathy (NERVARA Phase 2 trial), sarcoidosis, and ischemic injury models
Chronic low-grade inflammation is a root driver of many major chronic diseases, including cardiovascular disease, type 2 diabetes, cancer, Alzheimers disease, and arthritis